Efficacy of First-Line Antiretroviral Therapy in Jaipur: Predictive role of CD4+T cell count and Viral load count.

Abstract Background: ART has helped in managing the fatal HIV/AIDS with the easy accessibility of effective antiretroviral drugs which helps in maintaining the cellular immunity by inhibiting viral replication in people living with HIV (PLHIV). Routinely monitoring parameters from an early stage {i.e. baseline CD4+T cell count and Viral load count with follow up at every 3 and 6 months respectively} was beneficial in finding the incidence of drug resistance at an early stage. Thus, by determining the efficacy of first line ART also assisted us in predicting drug resistance among PLHIV using CD4+T cells and Viral load as parameters, considering all variables in the study (socio demographic variables, OI, mode of transmission, history of patient etc.) Aims & Objectives: To predict drug resistance through CD4+T cell and viral load for first line ART in tertiary care facilities in Jaipur, Rajasthan. Results: Among 300 participants, 65.33% participants achieved Viral load suppression and hence categorized as TND their CD4+T cell count was found >200 cell/µl, 12% participants appeared to fall in the category of LLV with viral load falling in between 50-999 copies/ml and CD4+T cell count <200 cell/µl, 22.67% participants were still found to persist detectable viral load (VL ≥1000 copies/ml) with CD4+T cell count <200 cell/µl viral failure. Conclusion: Persistent Viral load in LLV patients (50-999 copies/ml) and viral load ≥1000 copies/ml in viral failure patients indicates unsuppressed viral load, viral failure and prevalence of drug resistance at an early stage.

Institutions

Publication Details

Journal
Zenodo (CERN European Organization for Nuclear Research)
Published
2024-10-30
DOI
https://doi.org/10.5281/zenodo.15435439
Primary Topic
HIV/AIDS drug development and treatment
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Efficacy of First-Line Antiretroviral Therapy in Jaipur: Predictive role of CD4+T cell count and Viral load count.

Zenodo (CERN European Organization for Nuclear Research)
HIV/AIDS drug development and treatment
article

Efficacy of First-Line Antiretroviral Therapy in Jaipur: Predictive role of CD4+T cell count and Viral load count.

article en

Abstract

Abstract Background: ART has helped in managing the fatal HIV/AIDS with the easy accessibility of effective antiretroviral drugs which helps in maintaining the cellular immunity by inhibiting viral replication in people living with HIV (PLHIV). Routinely monitoring parameters from an early stage {i.e. baseline CD4+T cell count and Viral load count with follow up at every 3 and 6 months respectively} was beneficial in finding the incidence of drug resistance at an early stage. Thus, by determining the efficacy of first line ART also assisted us in predicting drug resistance among PLHIV using CD4+T cells and Viral load as parameters, considering all variables in the study (socio demographic variables, OI, mode of transmission, history of patient etc.) Aims & Objectives: To predict drug resistance through CD4+T cell and viral load for first line ART in tertiary care facilities in Jaipur, Rajasthan. Results: Among 300 participants, 65.33% participants achieved Viral load suppression and hence categorized as TND their CD4+T cell count was found >200 cell/µl, 12% participants appeared to fall in the category of LLV with viral load falling in between 50-999 copies/ml and CD4+T cell count <200 cell/µl, 22.67% participants were still found to persist detectable viral load (VL ≥1000 copies/ml) with CD4+T cell count <200 cell/µl viral failure. Conclusion: Persistent Viral load in LLV patients (50-999 copies/ml) and viral load ≥1000 copies/ml in viral failure patients indicates unsuppressed viral load, viral failure and prevalence of drug resistance at an early stage.

Zenodo (CERN European Organization for Nuclear Research)
Innovative Research (United States) (US)
Good health and well-being
Openalex Percentile: Top 61%
HIV/AIDS drug development and treatment
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Efficacy of First-Line Antiretroviral Therapy in Jaipur: Predictive role of CD4+T cell count and Viral load count. · Zenodo (CERN European Organization for Nuclear Research) (2024) | TGRS Research Map | TGRS